Liver metastases: Incidence and histogenesis;Lebermetastasen: Inzidenz und histogenetische einordnung

Zeitschrift fur Gastroenterologie

Volumn 43, Issue 10, 2005, Pages 1149-1157

  Kasper, H U ^a   Drebber, U ^a   Dries, V ^a   Dienes, H P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Histology; Liver metastases; Pathology; Prevalence; Primary tumor

Indexed keywords

CA 19-9 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; CYTOKERATIN 8; MELAN A; PROSTATE SPECIFIC ANTIGEN; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ANAPLASTIC CARCINOMA; BILE DUCT CARCINOMA; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; COLORECTAL CANCER; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MESENCHYMOMA; NEUROENDOCRINE TUMOR; NODULAR HYPERPLASIA; PANCREAS CANCER; REVIEW; STOMACH CANCER; UNIVERSITY HOSPITAL; VASCULAR TUMOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NEUROENDOCRINE; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFANT; LIVER; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REGISTRIES; SEX FACTORS;

EID: 27744592272     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858576     Document Type: Review

References (45)

1. Dimick JB, Cowan JA Jr, Knol JA et al. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003; 138 (2): 185-191
2. Tot T, Samii S. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis. Apmis 2003; 111 (12): 1075-1082
3. Gall EA. Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis. Arch Pathol 1960; 70: 226-232
4. Pickren JW, Tsukada Y, Lane WW. Liver metastasis: Analysis of autopsy data. In: Weiss L, Gilbert HA (Hrsg). Liver metastases. Boston: G.K. Hall & Co., 1982: 2-18
5. Shafqat A, Merchant M, Malik IA. Clinico-pathological features and survival of patients presenting with hepatic metastases: a retrospective analysis. J Pak Med Assoc 1996; 46 (5): 99-102
6. Fenster LF, Klatskin G. Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy. Am J Med 1961; 31: 238-248
7. Ishak KG, Goodman ZD, Stocker JT. Metastases. Tumors of the liver and Intrahepatic Bile DuctsAFIP Atlas of Tumor Pathology, 1999; 31: 343-349
8. Schulz W, Hagen C, Hort W. The distribution of liver metastases from colonic cancer. A quantitative postmortem study. Virchows Arch A Pathol Anat Histopathol 1985; 406 (3): 279-284
9. Wigmore SJ, Madhavan K, Redhead DN et al. Distribution of colorectal liver metastases in patients referred for hepatic resection. Cancer 2000; 89 (2): 285-287
10. Shirai Y, Wakai T, Ohtani T et al. Colorectal carcinoma metastases to the liver. Does primary tumor location affect its lobar distribution? Cancer 1996; 77 (11): 2213-2216
11. Melato M, Laurino L, Mucli E et al. Relationship between cirrhosis, liver cancer, and hepatic metastases. An autopsy study. Cancer 1989; 64(2): 455-459
12. Limmer A, Knolle PA. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch Immunol Ther Exp (Warsz) 2001; 49 (Suppl 1): S7-11
13. Varma V, Cohen C. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol 2004; 11 (5): 239-249
14. Rocken C, Carl-McGrath S, Grantzdorffer I et al. Ectopeptidases are differentially expressed in hepatocellular carcinomas. Int J Oncol 2004; 24 (3): 487-495
15. Lamps LW, Folpe AL. The diagnostic value of hepatocyte paraffin anti-body 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review. Adv Anat Pathol 2003; 10 (1): 39-43
16. Fan Z, van de Rijn M, Montgomery K et al. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003; 16(2): 137-144
17. Van Eyken P, Sciot R, Brock P et al. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology 1990; 17 (2): 101-107
18. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66(3): 167-179
19. Riopel MA, Klimstra DS, Godellas CV et al. Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol 1997; 21 (9): 1030-1036
20. Ochiai T, Yamamoto J, Kosuge T et al. Adenosquamous carcinoma with different morphologic and histologie components arising from the intrahepatic bile duct: report of a case. Hepatogastroenterology 1996; 43 (9): 663-666
21. Nakajima T, Kondo Y. A clinicopathologic study of intrahepatic cholangiocarcinoma containing a component of squamous cell carcinoma. Cancer 1990; 65 (6): 1401-1404
22. Jeng YM, Chen CL, Hsu HC. Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor. Am J Surg Pathol 2001; 25 (4): 516-520
23. Szekely E. Lymphoepithelioma-like cholangiocarcinoma (LELC) not associated with Epstein-Barr virus. Am J Surg Pathol 2001; 25 (11): 1464-1466
24. Steffani K, Erbersdobler A, Broering DC. [Primary squamous cell carcinoma of the liver. Surprising findings in dysontogenetic liver cysts]. Dtsch Med Wochenschr 2003; 128 (38): 1947-1950
25. Kaji R, Sasaki N, Tateishi I et al. A case report of primary hepatic squamous cell carcinoma that remarkably responded to low dose arterial injection of anti-cancer drugs. Kurume Med J 2003; 50 (1-2): 71-75
26. Moll R, Lowe A, Laufer J et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140 (2): 427-447
27. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13 (9): 962-972
28. Theodoropoulos GE, Lazaris AC, Panoussopoulos D et al. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma. J Surg Oncol 1995; 58(3): 176-183
29. Stenhouse G, Fyfe N, King G et al. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol 2004; 57 (4): 383-387
30. Rosai J. Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori 2003; 89 (5): 517-519
31. Tot T. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20 +/7- phenotype. Med Sci Monit 2004; 10 (5): BR139-143
32. Kennedy MT, Jordan RC, Berean KW et al. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004; 57 (9): 932-937
33. Mesquita P, Almeida R, Van Seuningen I et al. Coordinated expression of MUC2 and CDX-2 in mucinous carcinomas of the lung can be explained by the role of CDX-2 as transcriptional regulator of MUC2. Am J Surg Pathol 2004; 28(9): 1254-1255
34. Tornillo L, Moch H, Diener PA et al. CDX-2 immunostaining in primary and secondary ovarian carcinomas. J Clin Pathol 2004; 57 (6): 641-643
35. Nappi O, Mills SE, Swanson PE et al. Clear cell tumors of unknown nature and origin: a systematic approach to diagnosis. Semin Diagn Pathol 1997; 14(3): 164-174
36. Carlson JA, Slominski A, Linette GP et al. Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Am J Clin Pathol 2003; 120 (Suppl): S101-127
37. Terracciano LM, Glatz K, Mhawech P et al. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol 2003; 27 (10): 1302-1312
38. Emile JF, Theou N, Tabone S et al. Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol 2004; 2 (7): 597-605
39. Noguchi T, Takeno S, Kato T et al. Small cell carcinoma of the esophagus; clinicopathological and immunohistochemical analysis of six cases. Dis Esophagus 2003; 16 (3): 252-258
40. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000; 36 (5): 415-420
41. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999; 21 (1): 16-20
42. Kurokawa M, Nabeshima K, Akiyama Y et al. CD56: a useful marker for diagnosing Merkel cell carcinoma. J Dermatol Sci 2003; 31 (3): 219-224
43. Wick MR. Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol 2000; 17 (3): 194-203
44. Lucas DR, Bentley G, Dan ME et al. Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study. Am J Clin Pathol 2001; 115 (1): 11-17
45. Jaffe ES. Malignant lymphomas: pathology of hepatic involvement. Semin Liver Dis 1987; 7 (3): 257-268